Tag: ESC 2023
Nitrate reduces contrast-induced necropathy during coronary angiography
Inorganic nitrate reduces contrast-induced nephropathy (CIN), improves renal outcomes and reduces ca...
Ten-year NOTION trial data provide important insights on long-term TAVI outcomes and valve durability
Ten-year data from the NOTION trial—the longest-running clinical trial to date to compare outcom...
ESC 2023: Study assesses impact of using Heartflow FFRCT for diagnosing coronary artery disease
A study assessing the impact of the addition of adding coronary computed tomography angiography ...
ESC 2023: Prolonged clopidogrel monotherapy after PCI in high-risk ACS patients reduces bleeding and ischaemic events
Extended P2Y12 inhibitor monotherapy beyond 12 months after percutaneous coronary intervention (PCI...
ESC 2023: ADVENT trial shows PFA is non-inferior to thermal ablation for safety and efficacy in paroxysmal AF
Results of the first randomised trial comparing pulsed field ablation (PFA) to thermal ablation ...
ESC 2023: GE Healthcare showcases latest-generation handheld ultrasound scanner and AF tool
GE Healthcare has announced the launch of two new tools for the cardiology market, coinciding wi...
ESC 2023: Hot Line trials add weight to case for intravascular imaging during PCI
Data from three randomised trials and a meta-analysis presented at the European Society of Cardi...
ESC 2023: Siemens unveils Acuson Origin imaging platform
Siemens Healthineers has unveiled the Acuson Origin, a dedicated cardiovascular ultrasound system wi...
ESC 2023: Risk of MI recurrence higher in patients who do not take daily aspirin
Myocardial infarction (MI) patients who do not take daily aspirin have an elevated likelihood of rec...
